Review ArticleJournal of Young PharmacistsVol. 14 | Issue 2 | 2022 | pp. 133–139Open access
Contemporary COVID-19 Vaccines: The Science and Marketing
- 1,
- 2*,
- 2,
- 2,
- 3
- 1 Business Development, Group Pharmaceuticals, Bangalore, Karnataka, INDIA.
- 2 Development of Agricultural, Trust’s Shardabai Pawar Institute of Pharmaceutical Sciences and Research, Baramati, Maharashtra, INDIA.
- 3 Ashwin College of Pharmacy, Sangamner, Maharashtra, INDIA.
Published in Journal of Young Pharmacists
Correspondence: Atul Baravkar
Development of Agricultural, Trust’s Shardabai Pawar Institute of Pharmaceutical Sciences and Research, Baramati, Maharashtra, INDIA.
Email: atul200678@gmail.com
Copyright: © 2022 Manuscript Technomedia. This is an open access article.
- Published:
- Jun 8, 2022
- Received:
- Jul 19, 2021
- Accepted:
- Feb 12, 2022
How to cite
Chiplunkar, S., Baravkar, A., Paricharak, S., Masal, A., & Aher, N. (2022). Contemporary COVID-19 Vaccines: The Science and Marketing. Journal of Young Pharmacists, 14(2), 133–139. https://doi.org/10.5530/jyp.2022.14.27
Abstract
Objectives: The viral infection pandemic caused by SARS-CoV-2 has resulted in a flurry of research in the field of immunologicals. Scientific terms like antigen, antibody and immunoglobulins have entered the lexicon of citizens. Ending the pandemic through measures such as double masking, physical distancing and lockdowns have been imposed to break the chain of COVID-19 infection transmission, however, once again it is the vaccines that have proved worthy to improve immunity and halt the march of COVID-19. Methods: The vaccination process at optimal levels is aimed at desired antibodies. The impetus provided to vaccine technology commercialization is immense. mRNA vaccines have stolen the march, however, the traditional whole virion inactivated vaccine has made a comeback, new plasmid DNA technology vaccine has made a breakthrough, nasal vaccines are being designed, and recombinant protein subunit vaccine has given new affordability; oral vaccines are in the pipeline. Conclusion: Scientists and technologists have proved their worth through innovative vaccine work. This article reviews the science and marketing of COVID-19 vaccines.
Keywords
Subject
Article metadata
| Title | Contemporary COVID-19 Vaccines: The Science and Marketing |
|---|---|
| Authors | Sunil Chiplunkar; Atul Baravkar; Sukanya Paricharak; Apeksha Masal; Nitin Aher |
| Affiliations | Business Development, Group Pharmaceuticals, Bangalore, Karnataka, INDIA.; Development of Agricultural, Trust’s Shardabai Pawar Institute of Pharmaceutical Sciences and Research, Baramati, Maharashtra, INDIA.; Ashwin College of Pharmacy, Sangamner, Maharashtra, INDIA. |
| Corresponding author | atul200678@gmail.com |
| Journal | Journal of Young Pharmacists |
| Volume / Issue | Vol. 14, Issue 2 (2022) |
Also in this issue
- Role of the Unani System of Medicine in Countering Epidemic Diseases, Considering Coronavirus Pandemic -19pp. 140–155
- Human Salivary microRNA as Biomarkers in Oral Potentially Malignant Disorder-A Narrative Reviewpp. 156–159
- Unraveling the Immunomodulatory Potential of Cyprinus carpiopp. 160–164
- Rational Use of Antibiotics: An Area of Concernpp. 165–168
- Assessment of Anthelmintic Activity and in silico Study of Phytoconstituents in Decaschistia crotonifolia Wight & Arn. Root Extractpp. 169–173
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026